X

Advancements in Fertility Treatments: IVG vs. IVF

By: Ameena Qadri PharmD Candidate c/o 2027 Advancements in reproductive technology have considerably enhanced fertility treatments, with in-vitro fertilization (IVF)…

eMAR

New York Providing Accessibility: Pharmacies Providing Hormonal Birth Control Without a Prescription

Amanda Nakhul, Biomedical Sciences c/o 2027 Reproductive rights, specifically abortion, has been a topic of contention for decades. From being…

eMAR

FDA Approves Treatment for Early Symptomatic Alzheimer’s Disease, KisunlaTM (donanemab-azbt)

By: Katelyn Hoosein, PharmD Candidate c/o 2025             Alzheimer’s disease (AD) is a neurodegenerative disorder with symptoms that progressively worsen…

eMAR

Rho Chi Talks: Dr. Hyunah Cho Leads Novel Nano-Based Optical Imaging Agent Research for Cancer Surgical Treatment Following $745,000 Grant from the NIH

By: Jennalynn Fung, PharmD candidate c/o 2025 Dr. Hyunah Cho, Ph.D., an Assistant Professor in the Department of Pharmaceutical Sciences,…

eMAR

6th Year Perspective: A Case Study on How to Best Manage Complicated Chronic Disease in Rural, Peripatetic, and Nomadic Populations

By Jennalynn Fung, PharmD Candidate c/o 2025 Introduction I’m a final year pharmacy student completing my Advanced Pharmacy Practice Rotations.…

eMAR

From Weight Loss to Vision Loss: A Potential Risk of Semaglutide

By: Sariah Grant, PharmD Candidate c/o 2027            In June 2021, the Food and Drug Administration approved Novo Nordisk’s semaglutide,…

eMAR

6th Year Perspective: Behind the Scenes at Pfizer

Featuring: Simkho Shimonov, PharmD Candidate c/o 2025 By: Rebecca Sabzanov, PharmD Candidate c/o 2026 Simkho Shimonov, a dedicated and diligent…

eMAR

FDA’s New Blueprint for Cell-Based Therapies

By: Reyaz Mussaleen PharmD Candidate c/o 2027 IntroductionThe Food and Drug Administration (FDA) of the United States published a draft…

eMAR

FDA Accelerated Approval of Enhertu for Broad Treatment of HER2-Positive Solid Cancers

By: Nivaj Haque; PharmD Candidate c/o 2027 In recent years, advancements in oncology have transformed the treatment landscape for various…

eMAR

Rho Chi Talks: A Look into the St. John’s University Summer Research Program

By: Rosa Kang PharmD Candidate c/o 2027 Summer is a time of endless possibilities. During this time, St. John’s University…

eMAR